Katlama C - Search Results

1

The F4/AS01B HIV-1 Vaccine Candidate Is Safe and Immunogenic, But Does Not Show Viral Efficacy in Antiretroviral Therapy-Naive, HIV-1-Infected Adults: A Randomized Controlled Trial.

Dinges W, Girard PM, Podzamczer D, Brockmeyer NH, García F, Harrer T, Lelievre JD, Frank I, Colin De Verdière N, Yeni GP, Ortega Gonzalez E, Rubio R, Clotet Sala B, DeJesus E, Pérez-Elias MJ, Launay O, Pialoux G, Slim J, Weiss L, Bouchaud O, Felizarta F, Meurer A, Raffi F, Esser S, Katlama C, Koletar SL, Mounzer K, Swindells S, Baxter JD, Schneider S, Chas J, Molina JM, Koutsoukos M, Collard A, Bourguignon P, Roman F. Dinges W, et al. Among authors: katlama c. Medicine (Baltimore). 2016 Feb;95(6):e2673. doi: 10.1097/MD.0000000000002673. Medicine (Baltimore). 2016. PMID: 26871794 Free PMC article. Clinical Trial.

2

Treatment of central nervous system toxoplasmosis with pyrimethamine/sulfadiazine combination in 35 patients with the acquired immunodeficiency syndrome. Efficacy of long-term continuous therapy.

Leport C, Raffi F, Matheron S, Katlama C, Regnier B, Saimot AG, Marche C, Vedrenne C, Vilde JL. Leport C, et al. Among authors: katlama c. Am J Med. 1988 Jan;84(1):94-100. doi: 10.1016/0002-9343(88)90014-9. Am J Med. 1988. PMID: 3337134

3

Safety and efficacy of lamivudine-zidovudine combination therapy in antiretroviral-naive patients. A randomized controlled comparison with zidovudine monotherapy. Lamivudine European HIV Working Group.

Katlama C, Ingrand D, Loveday C, Clumeck N, Mallolas J, Staszewski S, Johnson M, Hill AM, Pearce G, McDade H. Katlama C, et al. JAMA. 1996 Jul 10;276(2):118-25. JAMA. 1996. PMID: 8656503 Clinical Trial.

4

[Risk factors of cerebral toxoplasmosis in patients with HIV infection. Definition of indications of primary prevention].

Leport C, Ambroise-Thomas P, Bazin C, Chène G, Derouin F, Katlama C, Mayaud C, Pelloux H, Raffi F, Vildé JL. Leport C, et al. Among authors: katlama c. Ann Med Interne (Paris). 1996;147(5):331-2. Ann Med Interne (Paris). 1996. PMID: 9033735 Review. French. No abstract available.

5

Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease.

Autran B, Carcelain G, Li TS, Blanc C, Mathez D, Tubiana R, Katlama C, Debré P, Leibowitch J. Autran B, et al. Among authors: katlama c. Science. 1997 Jul 4;277(5322):112-6. doi: 10.1126/science.277.5322.112. Science. 1997. PMID: 9204894 Clinical Trial.

6

Potential efficacy of fumagillin in intestinal microsporidiosis due to Enterocytozoon bieneusi in patients with HIV infection: results of a drug screening study. The French Microsporidiosis Study Group.

Molina JM, Goguel J, Sarfati C, Chastang C, Desportes-Livage I, Michiels JF, Maslo C, Katlama C, Cotte L, Leport C, Raffi F, Derouin F, Modaï J. Molina JM, et al. Among authors: katlama c. AIDS. 1997 Nov;11(13):1603-10. doi: 10.1097/00002030-199713000-00009. AIDS. 1997. PMID: 9365765 Clinical Trial.

7

Long-lasting recovery in CD4 T-cell function and viral-load reduction after highly active antiretroviral therapy in advanced HIV-1 disease.

Li TS, Tubiana R, Katlama C, Calvez V, Ait Mohand H, Autran B. Li TS, et al. Among authors: katlama c. Lancet. 1998 Jun 6;351(9117):1682-6. doi: 10.1016/s0140-6736(97)10291-4. Lancet. 1998. PMID: 9734884

8

Efficacy and tolerability of stavudine plus lamivudine in treatment-naive and treatment-experienced patients with HIV-1 infection.

Katlama C, Valantin MA, Matheron S, Coutellier A, Calvez V, Descamps D, Longuet C, Bonmarchand M, Tubiana R, De Sa M, Lancar R, Agut H, Brun-Vezinet F, Costagliola D. Katlama C, et al. Ann Intern Med. 1998 Oct 1;129(7):525-31. doi: 10.7326/0003-4819-129-7-199810010-00003. Ann Intern Med. 1998. PMID: 9758571

9

[Epidemiologic characteristics of cerebral toxoplasmosis in 399 HIV-infected patients followed between 1983 and 1994].

Bossi P, Caumes E, Astagneau P, Li TS, Paris L, Mengual X, Katlama C, Bricaire F. Bossi P, et al. Among authors: katlama c. Rev Med Interne. 1998 May;19(5):313-7. doi: 10.1016/s0248-8663(98)80100-8. Rev Med Interne. 1998. PMID: 9775164 French.

10

A dose-ranging study to evaluate the safety and efficacy of abacavir alone or in combination with zidovudine and lamivudine in antiretroviral treatment-naive subjects.

Staszewski S, Katlama C, Harrer T, Massip P, Yeni P, Cutrell A, Tortell SM, Harrigan RP, Steel H, Lanier RE, Pearce G. Staszewski S, et al. Among authors: katlama c. AIDS. 1998 Nov 12;12(16):F197-202. doi: 10.1097/00002030-199816000-00001. AIDS. 1998. PMID: 9833847 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

941 results

Search Page

Filters